Who is sponsoring NCT05606250?

NCT05606250 is sponsored by Universidad Europea de Madrid.

What drugs are being tested in NCT05606250?

Interventions in NCT05606250: Ultrasound-Guided Percutaneous Neuromodulation.

What condition does NCT05606250 study?

NCT05606250 studies ACL Injury.

Is NCT05606250 still recruiting?

NCT05606250 is currently completed. Last updated 21 March 2024.

Last reviewed 2024-03-21 · How we verify

NCT05606250: NMPeLCA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ultrasound-guided Percutaneous Neuromodulation in Anterior Cruciate Reconstruction

Completed NA Last updated 21 March 2024

What this trial tests

NA trial testing Ultrasound-Guided Percutaneous Neuromodulation in ACL Injury in 70 participants. Completed in 15 January 2024.

Timeline

20 January 2022

Primary endpoint
20 April 2022

15 January 2024

Quick facts

Lead sponsor	Universidad Europea de Madrid
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	70
Start date	20 January 2022
Primary completion	20 April 2022
Estimated completion	15 January 2024
Sites	1 location across Spain

Drugs / interventions tested

Ultrasound-Guided Percutaneous Neuromodulation

Conditions studied

ACL Injury — all drugs for ACL Injury →

Sponsor

Universidad Europea de Madrid

Who can join

Adults 18 to 55, any sex, with ACL Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of the study is to demonstrate the efficacy of the ultrasound-guided percutaneous neuromodulation technique in the femoral nerve in patients who underwent surgery for the anterior cruciate ligament.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

A Systematic Review of Temporary Peripheral Nerve Stimulation for Postoperative Pain Management in Orthopedic Surgery.
Harris JC, Pierson CJ, Konda C, Jain NB. · · 2025 · PMID 41409093 · DOI 10.1155/anrp/8477771
Short-term effects of percutaneous electrical nerve stimulation on pain and muscle function in patients undergoing anterior cruciate ligament surgery: a randomized clinical trial.
Caballero-López J, Navarro-Santana M, Almazán-Polo J, García-Sanz F, et al · · 2025 · PMID 40365171 · DOI 10.3389/fresc.2025.1501703

Verify or expand the search:

Other recruiting trials for ACL Injury

Currently open trials in the same condition.

NCT06529679 — Michigan Split-belt Treadmill Training Program to Improve Acute Knee Biomechanics After ACL Reconstruction · NA · recruiting
NCT06442319 — The Efficiency and Safety of PRP Treatment After Anterior Cruciate Ligament Reconstruction. · NA · recruiting
NCT06524869 — Association Between Neuromuscular Parameters and Functional Assessment After ACL Reconstruction · recruiting
NCT07387939 — ACL Reconstruction in Patients Aged 50 Years and Older · active not recruiting
NCT06194682 — Anterior Cruciate Ligament Study · recruiting

Other Universidad Europea de Madrid trials

Trials by the same sponsor.

NCT07506837 — Effects of an HABIT-ILE-Based Intervention in Children With Cerebral Palsy · NA · not yet recruiting
NCT07470268 — Impact of Hypertrophy-oriented Resistance Training on Muscle Mass and Quality of Life in Patients With Unresectable Panc · NA · not yet recruiting
NCT07494903 — Effects of Vibrational Therapy on Pelvic Floor Muscle Strength and Tone in Healthy Women · NA · not yet recruiting
NCT07524010 — Multi-Omics Characterization of Percutaneous Electrolysis in Low Back Pain · Phase 1 · enrolling by invitation
NCT07484776 — Metabolic Flexibility in Patients With Early Triple-negative Breast Cancer · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05606250 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universidad Europea de Madrid
Last refreshed: 21 March 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05606250.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing